Pharming Group (PHAR)
10.00
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
Pharming Group Gross Profit Margin (Quarterly): 91.24% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 91.24% |
| September 30, 2023 | 87.56% |
| June 30, 2023 | 89.57% |
| March 31, 2023 | 90.42% |
| December 31, 2022 | 88.52% |
| September 30, 2022 | 95.61% |
| June 30, 2022 | 91.97% |
| March 31, 2022 | 89.54% |
| December 31, 2021 | 89.31% |
| September 30, 2021 | 88.63% |
| June 30, 2021 | 90.65% |
| March 31, 2021 | 88.88% |
| December 31, 2020 | 88.36% |
| September 30, 2020 | 89.47% |
| June 30, 2020 | 88.64% |
| March 31, 2020 | 89.07% |
| December 31, 2019 | 88.76% |
| September 30, 2019 | 88.45% |
| June 30, 2019 | 87.01% |
| March 31, 2019 | 84.61% |
| December 31, 2018 | 82.76% |
| September 30, 2018 | 83.59% |
| June 30, 2018 | 85.30% |
| March 31, 2018 | 82.97% |
| December 31, 2017 | 86.23% |
| Date | Value |
|---|---|
| September 30, 2017 | 83.79% |
| June 30, 2017 | 87.21% |
| March 31, 2017 | 89.02% |
| December 31, 2016 | 81.28% |
| September 30, 2016 | 64.05% |
| June 30, 2016 | 55.78% |
| March 31, 2016 | 70.33% |
| December 31, 2015 | 54.25% |
| September 30, 2015 | 57.48% |
| June 30, 2015 | 60.65% |
| March 31, 2015 | 43.71% |
| December 31, 2014 | 96.23% |
| September 30, 2014 | 34.63% |
| June 30, 2014 | 48.30% |
| March 31, 2014 | 14.24% |
| December 31, 2013 | 30.65% |
| September 30, 2013 | 66.15% |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | 86.36% |
| September 30, 2012 | 56.26% |
| June 30, 2012 | -211.1% |
| March 31, 2012 | 55.13% |
| December 31, 2011 | -51.23% |
| September 30, 2011 | -49.60% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
87.01%
Minimum
Jun 2019
95.61%
Maximum
Sep 2022
89.56%
Average
89.07%
Median
Mar 2020
Gross Profit Margin (Quarterly) Benchmarks
| uniQure NV | -32.08% |
| ProQR Therapeutics NV | -- |
| Merus NV | -- |
| argenx SE | 90.30% |
| Pharvaris NV | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -5.11% |
| Return on Assets | -2.42% |
| Return on Invested Capital | -3.09% |
| Profit Margin (Quarterly) | -3.85% |
| Operating Margin (Quarterly) | -19.49% |
| Return on Net Operating Assets | -4.82% |